Latest News of SRPT
Is Sarepta Therapeutics, Inc. (SRPT) the Most Promising Biotech Stock According to Hedge Funds?
By Yahoo! Finance |
2 weeks ago
A list of the 10 most promising biotech stocks was recently compiled, featuring Sarepta Therapeutics, Inc. (NASDAQ:SRPT). The biotech sector's growth, market trends, and potential impact of federal in...
Is Sarepta Therapeutics, Inc. (SRPT) One of the Best Revenue Growth Stocks to Buy According to Analysts?
By Yahoo! Finance |
1 month ago
A recent article analyzes Sarepta Therapeutics, Inc. (NASDAQ: SRPT) against other top revenue growth stocks recommended by analysts. It discusses the impact of recent Fed rate cuts and market trends....
Sarepta Therapeutics (SRPT): Soaring with Successful Therapies and Cash Flow Positivity
By Yahoo! Finance |
1 month ago
Insider Monkey's recent article highlights the 16 Best Mid Cap Growth Stocks, focusing on Sarepta Therapeutics Inc. (NASDAQ:SRPT)....
-
Sarepta Therapeutics, Inc. (SRPT): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance | 1 month agoThe article discusses the risks and challenges of investing in biotechnology stocks, highlighting the importance of thorough research and diversification. It also evaluates Sarepta Therapeutics, Inc. ...
-
Sarepta Therapeutics, Inc. (SRPT): This Biotech Stock Should Be On Your Radar
By Yahoo! Finance | 1 month agoA list of top biotech stocks to invest in was compiled, focusing on Sarepta Therapeutics, Inc. Amid a growing biotechnology industry, AI-driven drug discovery and promising outlooks for companies like...
-
Sarepta Therapeutics (NASDAQ:SRPT) A Bull Case Theory
By Yahoo! Finance | 3 months agoSarepta Therapeutics (SRPT) has gained 51% year-to-date, with a closing price of $146.03 on July 29th. Analysts are bullish on SRPT, expecting significant growth driven by the successful launch of Ele...
-
Insider Sale: EVP, General Counsel Ryan Brown Sells 38,957 Shares of Sarepta Therapeutics Inc (SRPT)
By Yahoo! Finance | 4 months agoRyan Brown, EVP and General Counsel of Sarepta Therapeutics Inc (NASDAQ:SRPT), sold 38,957 shares on June 25, 2024. The insider now holds 17,129 shares....
-
Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance | 4 months agoSarepta Therapeutics Inc. has obtained expanded US approval for its gene therapy to treat more children with a fatal muscle disease, despite lacking clear evidence of its benefits in clinical trials....